MPS Pharmaa - Quaterly Results

13 Feb 2024 Evaluate
The revenue for the December 2023 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2023 is Rs. -2.15 millions as compared to Net Loss of Rs. -2.59 millions of corresponding quarter ended December 2022 Operating profit Margin for the quarter ended December 2023 improved to -1.84% as compared to -2.26% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.32 0.00
Other Income 0.00 0.00 0.00 0.92 0.00 0.00 0.23 2.58 -91.09
PBIDT -1.84 -2.26 -18.58 -4.95 -6.38 -22.41 -9.25 -4.18 121.29
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00
PBDT -1.84 -2.26 -18.58 -4.95 -6.38 -22.41 -9.26 -4.19 121.00
Depreciation 0.37 0.37 0.00 1.11 1.09 1.83 1.46 5.14 -71.60
PBT -2.21 -2.63 -15.97 -6.06 -7.47 -18.88 -10.72 -9.33 14.90
TAX -0.06 -0.04 50.00 -0.18 -0.14 28.57 -0.21 -7.91 -97.35
Deferred Tax -0.06 -0.04 50.00 -0.18 -0.14 28.57 -0.21 -4.32 -95.14
PAT -2.15 -2.59 -16.99 -5.88 -7.33 -19.78 -10.51 -1.42 640.14
Equity 191.11 191.11 0.00 191.11 191.11 0.00 191.11 191.11 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1306.25 0.00

MPS Pharmaa Share Price

3.21 0.00 (0.00%)
22-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.